interview_prep_doc / art_PQcF_Ek-Rzg

Content

{
  "markdown": "# PeakHealth Interview Prep\n## Questions to Ask Stephanie Tilenius\n\n---\n\n## 1. Interviewer Summary\n\nStephanie Tilenius is the CEO and Founder of PeakHealth, which she launched in January 2025. Her career is one of the more remarkable in consumer technology: she built Google Wallet, Google Offers, and Google Shopping Express from scratch as VP of Commerce & Payments at Google; scaled PayPal Merchant Services from zero to a multi-billion dollar business; and led a major marketplace turnaround as SVP/GM at eBay. Before any of that, she co-founded PlanetRx in 1998 \u2014 one of the earliest online pharmacies \u2014 and took it public in 1999.\n\nHer most directly relevant chapter for this conversation is Vida Health, the digital health company she founded and ran for 12 years before launching PeakHealth. That tenure gives her rare, firsthand scar tissue in consumer health product-building \u2014 she's not a Big Tech executive parachuting into healthcare; she's someone who has lived the operational and regulatory complexity of the space for over a decade.\n\nShe is also a Venture Advisor at AI Fund, which means she's thinking about AI infrastructure and partnerships at a level beyond most CEOs.\n\n**What she will likely probe in this interview:**\n- Your 0-to-1 execution instincts and whether you've shipped something real, not just managed a roadmap\n- AI fluency \u2014 specifically whether you understand agentic systems and where AI actually moves the needle in care delivery\n- Consumer product taste and design judgment\n- Healthcare domain understanding: EMR constraints, clinical stakeholder dynamics, regulatory environment\n- Whether you can own IC work *and* lead \u2014 she's building a lean team and needs someone who can do both\n\n**Shared context worth leaning into:**\n- Both of you have built and shipped consumer-facing AI products from scratch (Streamio/Fintellect vs. Vida Health/PeakHealth)\n- Both of you have deep technical backgrounds paired with product and business leadership\n- Both have experience in regulated, health-adjacent consumer spaces\n- Her PlanetRx founding story rhymes with your 0-to-1 experience building Fintellect and Streamio in regulated consumer domains\n\nThis is a CEO-level interview, which means it will likely feel more like a strategic conversation than a structured behavioral screen. Thoughtful questions signal that you've done the work, that you think like a business owner, and that you're evaluating fit as seriously as she is.\n\n---\n\n## 2. Best Questions to Ask Stephanie Tilenius\n\n---\n\n### A. Interviewer Experience and Rapport\n\n**Question 1.**\n> **\"You co-founded PlanetRx in 1998 \u2014 one of the earliest online pharmacy and disease management companies \u2014 and now you're building PeakHealth. What did you learn from that first attempt at reimagining healthcare delivery that's directly shaping how you're architecting PeakHealth today?\"**\n\n**Why this is a good question:** It demonstrates deep research into her career arc, invites reflection on hard-won lessons, and signals genuine curiosity about the company's strategic DNA \u2014 not just its current state. It also opens a peer-level conversation rather than a standard interview exchange.\n\n---\n\n**Question 2.**\n> **\"You ran Vida Health for 12 years before founding PeakHealth. What was the moment or insight that made you say 'the next company needs to be built differently' \u2014 and how does the longevity plus AI angle represent a fundamentally different thesis than what you pursued at Vida?\"**\n\n**Why this is a good question:** This shows you've done the homework on her full journey and surfaces the strategic pivot logic \u2014 critical for understanding what PeakHealth is actually optimizing for versus prior attempts. It also frames Vida as a foundation, not a failure.\n\n> *Softened framing if needed:* \"I'd love to understand the evolution from Vida to PeakHealth \u2014 what carried forward and what you deliberately left behind.\"\n\n---\n\n**Question 3.**\n> **\"At Google you built Google Wallet and Google Offers from scratch, and at PayPal you scaled Merchant Services from zero to a multi-billion dollar business. When you think about applying that 0-to-1 consumer product muscle to healthcare, where do you find the biggest translation challenges \u2014 and where does it actually transfer cleanly?\"**\n\n**Why this is a good question:** This connects her Big Tech consumer product background to the healthcare context, surfaces her mental model for what's genuinely hard about this space, and positions you as someone who thinks in frameworks rather than just executing tasks.\n\n---\n\n### B. Role and Team Dynamics\n\n**Question 4.**\n> **\"For this PM role, what does a genuinely successful first 90 days look like to you \u2014 not just ramp activities, but a concrete outcome or artifact that would make you say 'yes, this person gets it'?\"**\n\n**Why this is a good question:** This clarifies the real bar for early success and reveals whether the role needs immediate execution or a longer discovery phase \u2014 critical for evaluating fit and calibrating your own expectations going in.\n\n---\n\n**Question 5.**\n> **\"The JD mentions owning both consumer product vision and AI automation systems for care delivery \u2014 those can be two very different product muscles. How do you see those two workstreams being balanced right now, and is there one that's more urgent given where the company is?\"**\n\n**Why this is a good question:** This surfaces prioritization reality versus the idealized job description, and signals that you've read carefully enough to notice the potential tension between consumer UX work and clinical/ops automation. It's the kind of question a senior PM asks \u2014 not a candidate who just wants to know what they'll be doing.\n\n---\n\n**Question 6.**\n> **\"How is the product team currently structured relative to engineering and clinical? Is this PM role expected to be the first dedicated PM, or are there others \u2014 and how does product decision-making flow between those functions today?\"**\n\n**Why this is a good question:** This reveals team maturity, whether this is a solo PM situation, and how much cross-functional navigation will be required. All of that is critical for evaluating the actual scope and leverage of the role.\n\n> *Softened framing if the question feels too blunt:* \"I want to make sure I understand the current product motion \u2014 how decisions are made and where this role plugs in \u2014 so I can hit the ground running.\"\n\n---\n\n**Question 7.**\n> **\"Given that your Chief Longevity Officer has a large public following and your Founding Medical Director comes from Peter Attia's practice, how does clinical opinion factor into product prioritization? When clinical instinct and product or data signals diverge, how does the team resolve that?\"**\n\n**Why this is a good question:** Healthcare PMs live or die by their ability to navigate clinical stakeholders. Understanding the power dynamics early is essential \u2014 and it signals you're thinking about real execution challenges, not just the product surface.\n\n---\n\n### C. Technical Environment\n\n**Question 8.**\n> **\"The JD emphasizes AI-forward product thinking and owning AI automation systems for care. What does the current AI stack look like \u2014 are you building on top of foundation model APIs, fine-tuning proprietary models, or something more bespoke \u2014 and where do you see the biggest technical leverage points for the PM to influence?\"**\n\n**Why this is a good question:** This signals genuine technical depth and helps you understand whether the AI work is primarily integration and orchestration (directly analogous to your multi-agent work at Streamio) or deeper model-level work. It also opens a substantive technical conversation where you can contribute, not just listen.\n\n---\n\n**Question 9.**\n> **\"For the EMR and clinical data layer, are you building on top of an existing platform like Elation or Canvas, or is there a proprietary clinical data model being developed? How much of the PM's work will involve navigating EMR constraints versus greenfield product surface?\"**\n\n**Why this is a good question:** EMR integration is one of the most painful constraints in digital health product work. Asking this early signals domain sophistication and helps you evaluate the actual complexity of the role before you're in it.\n\n---\n\n**Question 10.**\n> **\"The JD mentions prototyping with AI tools and running quick A/B tests. What does the current experimentation infrastructure look like \u2014 is there a feature flagging system, analytics pipeline, or is this something the PM would help build out from scratch?\"**\n\n**Why this is a good question:** This reveals the maturity of the data and experimentation stack, which directly affects how much time you'll spend building infrastructure versus running experiments. It's a practical question that shows you've thought about what execution actually requires.\n\n---\n\n### D. Culture and Working Style\n\n**Question 11.**\n> **\"You've led large organizations at eBay and Google and also co-founded companies \u2014 you've seen both ends of the autonomy spectrum. How would you describe the working style you're cultivating at PeakHealth: how much latitude does a PM get to set direction versus how much alignment with you and the CTO is expected before moving?\"**\n\n**Why this is a good question:** This directly surfaces the autonomy/alignment balance from the person who sets the culture \u2014 critical for evaluating whether this is a \"build and show\" or \"align then build\" environment. The answer will tell you a lot about day-to-day life in the role.\n\n---\n\n**Question 12.**\n> **\"When a PM has a strong product conviction that conflicts with what engineering says is feasible or what the clinical team says is appropriate, what does healthy disagreement look like on your team \u2014 and can you give me an example of how that's played out recently?\"**\n\n**Why this is a good question:** This tests for psychological safety and reveals the actual conflict resolution culture \u2014 especially important in a company where clinical authority can easily override product judgment. An example-based answer will tell you far more than a values statement.\n\n---\n\n**Question 13.**\n> **\"PeakHealth is still early-stage. How do you think about the balance between moving fast on consumer product iteration and the higher stakes of healthcare \u2014 where a bad experience isn't just churn, it's a patient outcome?\"**\n\n**Why this is a good question:** This surfaces the CEO's philosophy on velocity versus rigor in a regulated, high-stakes domain \u2014 and signals that you're thinking about the unique responsibility that comes with health products, not just shipping speed.\n\n---\n\n### E. Growth and Development\n\n**Question 14.**\n> **\"You've written publicly about putting consumers in control of their healthcare \u2014 going back to your 2014 LinkedIn article. As someone who's been thinking about this problem for over a decade, what do you think is the most important thing a PM joining PeakHealth today needs to learn or unlearn coming from outside healthcare?\"**\n\n**Why this is a good question:** This references her published thinking to show genuine research and invites a mentorship-framing \u2014 revealing what she values in PM development and what blind spots she's actively watching for on the team.\n\n---\n\n**Question 15.**\n> **\"For a PM who performs exceptionally well in this role, what does the growth path look like \u2014 is there a VP of Product or Head of Product role on the horizon, or is the expectation that this person grows into a broader leadership seat as the company scales?\"**\n\n**Why this is a good question:** This directly assesses career trajectory and whether the company has thought about PM leadership development \u2014 important for someone with 12+ years of experience evaluating long-term fit, not just the immediate role.\n\n---\n\n### F. Strategy and Vision\n\n**Question 16.**\n> **\"The JD describes PeakHealth as rebuilding the U.S. healthcare model from sick care to preventive care. In the near term \u2014 say the next 18 months \u2014 what are the two or three product bets that you believe will most define whether that vision is real or just positioning?\"**\n\n**Why this is a good question:** This forces specificity on strategy and reveals whether the CEO has a crisp product thesis or is still in discovery \u2014 critical for evaluating whether the role has clear direction or requires the PM to create it from scratch.\n\n---\n\n**Question 17.**\n> **\"Longevity as a category is getting crowded fast \u2014 Function Health, Hone, Lifeforce, and others are all competing for similar consumers. What's the moat you're building at PeakHealth, and how does the AI layer specifically create defensibility that a well-funded competitor can't easily replicate?\"**\n\n**Why this is a good question:** This shows competitive awareness and pushes for strategic clarity on differentiation \u2014 the kind of question a strong PM asks before joining, and one that signals you think like a business owner, not just a feature builder.\n\n---\n\n**Question 18.**\n> **\"You're simultaneously a Venture Advisor at AI Fund and building PeakHealth. How are you thinking about the intersection of those two roles \u2014 are there AI capabilities or partnerships coming out of AI Fund that could accelerate PeakHealth's roadmap?\"**\n\n**Why this is a good question:** This surfaces a potentially important strategic resource that isn't publicly discussed and shows you've read her full profile carefully. It also frames the dual role as a potential asset rather than a concern \u2014 which is the right approach.\n\n> *Note:* Keep this question curious and forward-looking. Do not imply divided attention or conflict of interest. See **Section 4** for more on this.\n\n---\n\n### G. Shared Context \u2014 Peer-Level Technical Dialogue\n\n**Question 19.**\n> **\"I've been building multi-agent AI orchestration systems at Streamio \u2014 coordinating specialized agents across health, insurance, and financial domains \u2014 and I'm curious how you're thinking about agentic AI in the clinical workflow at PeakHealth. Are you exploring agents that can act on behalf of physicians or patients, or is the current focus more on AI-assisted decision support?\"**\n\n**Why this is a good question:** This directly connects your hands-on multi-agent work (OpenClaw framework, 40+ agent tools in Vantage) to PeakHealth's AI roadmap. It establishes technical credibility without being boastful, and opens a substantive product conversation with the CEO on her own terms.\n\n---\n\n**Question 20.**\n> **\"PlanetRx was one of the earliest attempts to bring pharmacy and disease management online \u2014 and I've been thinking about similar distribution challenges building Fintellect and Streamio in regulated-adjacent spaces like finance and health. What do you think the regulatory and trust environment looks like for longevity care in 2025 versus what you faced in 1999, and how is that shaping your go-to-market approach?\"**\n\n**Why this is a good question:** This creates genuine peer-level dialogue by connecting your own 0-to-1 experience in regulated consumer spaces to her founding story. It's not a flattery question \u2014 it's a substantive comparison that invites a real strategic answer.\n\n---\n\n## 3. Best Conversation Starters\n\nUse one of these in the first 60\u201390 seconds to set the tone before the formal questions begin.\n\n### Starter 1 \u2014 Reference Her Published Thinking\n> \"I went back and read your 2014 LinkedIn article \u2014 'Tomorrow's Healthcare Puts Consumers in Control Like Amazon for Shopping' \u2014 and it struck me how much of what you wrote then is still the unsolved problem. I'd love to hear how your thinking has evolved from Vida to PeakHealth.\"\n\n### Starter 2 \u2014 Acknowledge the Long Arc\n> \"I noticed you co-founded PlanetRx back in 1998 \u2014 one of the first online pharmacies \u2014 which means you've been working on this consumer health access problem for over 25 years. That's a rare kind of conviction. I'm curious what keeps pulling you back to this space.\"\n\n### Starter 3 \u2014 Lead With Shared Technical Ground\n> \"I've been building multi-agent AI systems for health and financial workflows at Streamio, so when I saw PeakHealth's AI-forward positioning I was genuinely excited \u2014 I'd love to compare notes on where you think agentic AI actually moves the needle in care delivery versus where it's still mostly hype.\"\n\n---\n\n## 4. Topics to Handle Carefully\n\n### Topic 1 \u2014 Vida Health's Ending\n**The risk:** It's unclear whether Vida Health wound down, was acquired, or is still operating after Stephanie's departure in late 2024. Asking directly why it ended \u2014 or implying it was a failure \u2014 could put her on the defensive at the start of a relationship-building conversation.\n\n**Ask this instead:**\n> \"Vida Health gave you 12 years of firsthand experience in consumer health product-building. What's the most important thing you're carrying forward into PeakHealth from that chapter?\"\n\n**Softening phrases to keep handy:**\n- \"lessons carried forward from Vida...\"\n- \"building on what you learned at Vida...\"\n- \"the evolution from Vida to PeakHealth...\"\n\n---\n\n### Topic 2 \u2014 The AI Fund Dual Role\n**The risk:** Framing her Venture Advisor role at AI Fund as a distraction or a conflict of interest could read as skeptical or presumptuous \u2014 especially in a first conversation with the CEO.\n\n**Ask this instead:**\n> \"You're a Venture Advisor at AI Fund while building PeakHealth \u2014 are there AI capabilities or partnerships coming out of that network that could accelerate PeakHealth's roadmap?\"\n\nThis reframes the dual role as a potential strategic asset (which it may genuinely be) rather than a concern.\n\n---\n\n### Topic 3 \u2014 Team Size, Funding, and Runway\n**The risk:** PeakHealth launched in January 2025 and team composition is not publicly detailed. Questions that probe headcount or runway can expose skepticism about whether the company is sufficiently resourced \u2014 a bad signal to send to the CEO in an early-stage interview.\n\n**Ask this instead:**\n> \"Given where the company is right now, how are you thinking about prioritization \u2014 what's the PM's most important focus in the first 60 to 90 days?\"\n\nThis gets at the same underlying question (is the company resourced to execute?) through a lens of roadmap and prioritization rather than headcount or burn.\n\n---\n\n## 5. Best Questions to Prioritize During the Call\n\nIf the conversation moves fast and you only get five questions, these are the highest-signal ones:\n\n1. **Question 4 \u2014 First 90 Days** \u2014 Clarifies the real bar for success and whether the role needs immediate execution or discovery. Nothing is more important to understand before you accept an offer.\n\n2. **Question 16 \u2014 18-Month Product Bets** \u2014 Forces specificity on strategy. If she can't name two or three concrete bets, that tells you something important about the company's current state.\n\n3. **Question 5 \u2014 Consumer Product vs. AI Automation Balance** \u2014 Surfaces the prioritization reality behind the JD. The answer will tell you what you're actually signing up to do.\n\n4. **Question 19 \u2014 Agentic AI in Clinical Workflow** \u2014 Opens the most substantive technical conversation and directly connects your Streamio work to PeakHealth's roadmap. This is your best opportunity to demonstrate peer-level credibility.\n\n5. **Question 11 \u2014 Autonomy vs. Alignment** \u2014 Reveals the day-to-day working culture from the person who sets it. Critical for evaluating fit at a company this early-stage.\n\n---\n\n## 6. Suggested Call Flow\n\nUse this sequence to make the conversation feel natural rather than like a questionnaire.\n\n**Opening \u2014 Establish rapport (first 2\u20133 minutes)**\n> \"I went back and read your 2014 LinkedIn article on consumer-controlled healthcare, and it struck me how much of that vision is still the unsolved problem. I'd love to hear how your thinking has evolved from Vida to PeakHealth.\"\n\n**After she shares her background and founding story \u2014 go deeper on strategy**\n> \"Given where PeakHealth is today, what are the two or three product bets you believe will most define whether the preventive care thesis is real in the next 18 months?\"\n\n**When discussing the role \u2014 get specific on execution**\n> \"What does a genuinely successful first 90 days look like to you \u2014 not just ramp activities, but a concrete outcome that would make you say 'this person gets it'?\"\n\n**When the technical conversation opens \u2014 bring your own context**\n> \"I've been building multi-agent orchestration systems at Streamio across health, insurance, and financial domains \u2014 I'm curious whether you're exploring agentic AI that can act on behalf of physicians or patients, or whether the current focus is more on AI-assisted decision support.\"\n\n**Near the end \u2014 culture and growth**\n> \"When a PM has a strong product conviction that conflicts with what engineering or the clinical team says, what does healthy disagreement look like on your team?\"\n\n**Closing \u2014 forward-looking and collaborative**\n> \"I'm genuinely excited about what you're building here \u2014 before we wrap up, is there anything about my background or the work I've shipped that you'd want to dig into further?\"\n\n---\n\n## 7. Final Recommended Question Set\n\nIf time is short and you need a tight list of four to six questions, use these:\n\n1. What does a genuinely successful first 90 days look like \u2014 not just ramp activities, but a concrete outcome that would make you say \"this person gets it\"?\n2. In the next 18 months, what are the two or three product bets that will most define whether the preventive care vision is real or just positioning?\n3. How do you see the consumer product vision and AI automation workstreams being balanced right now \u2014 and which is more urgent?\n4. I've been building multi-agent AI orchestration systems at Streamio \u2014 are you exploring agents that can act on behalf of physicians or patients, or is the current focus more on AI-assisted decision support?\n5. How would you describe the working style you're cultivating at PeakHealth \u2014 how much latitude does a PM get to set direction versus aligning with you and the CTO first?\n6. What's the moat you're building at PeakHealth, and how does the AI layer create defensibility that a well-funded competitor can't easily replicate?\n\n---\n\n## 8. Strong Closing Line\n\nUse this \u2014 or a close variation \u2014 to end the conversation on a memorable, grounded note:\n\n> \"I've spent the last year building multi-agent AI systems from scratch across health, insurance, and financial workflows \u2014 shipping real products, navigating regulated consumer spaces, and doing the IC work myself. What you're building at PeakHealth sits exactly at the intersection of everything I've been working toward. I'd love to be part of it.\"\n\n---\n\n## 9. Final Reminder\n\nThis conversation should demonstrate:\n\n- **You've done the work.** You know her career, her published thinking, and PeakHealth's competitive landscape \u2014 not just the job description.\n- **You think like a business owner.** Your questions probe strategy, moat, and prioritization \u2014 not just role logistics.\n- **You have genuine peer-level technical depth.** The multi-agent AI conversation is your strongest signal \u2014 use it.\n- **You've shipped real things.** Streamio, Fintellect, Vantage \u2014 these are 0-to-1 products in regulated consumer spaces. That's the exact profile she's hiring for.\n- **You're evaluating fit, not just auditioning.** The best candidates ask the best questions. That's the impression you want to leave.",
  "source_artifact_id": "art_joRzI86aLXE",
  "source_kind": "candidate_questions",
  "doc_type": "questions_to_ask"
}